Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBOTM dual-therapy stent: What we plan to learn from REDUCE

Harry Suryapranata; Giuseppe De Luca

doi:10.2217/fca.14.81

Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO^TM dual-therapy stent: What we plan to learn from REDUCE

Harry Suryapranata, Giuseppe De Luca

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	17-20
Number of pages	4
Journal	Future Cardiology
Volume	11
Issue number	1
DOIs	https://doi.org/10.2217/fca.14.81
Publication status	Published - 1 Jan 2015
Externally published	Yes

Access to Document

10.2217/fca.14.81

Cite this

@article{b0b3282d37604a95840b6596ded45a82,

title = "Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBOTM dual-therapy stent: What we plan to learn from REDUCE",

author = "Harry Suryapranata and {De Luca}, Giuseppe",

year = "2015",

month = jan,

day = "1",

doi = "10.2217/fca.14.81",

language = "English",

volume = "11",

pages = "17--20",

journal = "Future Cardiology",

issn = "1479-6678",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBOTM dual-therapy stent

T2 - What we plan to learn from REDUCE

AU - Suryapranata, Harry

AU - De Luca, Giuseppe

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84921652688&partnerID=8YFLogxK

U2 - 10.2217/fca.14.81

DO - 10.2217/fca.14.81

M3 - Comment/debate

SN - 1479-6678

VL - 11

SP - 17

EP - 20

JO - Future Cardiology

JF - Future Cardiology

IS - 1

ER -

Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBOTM dual-therapy stent: What we plan to learn from REDUCE

Access to Document

Other files and links

Cite this

Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO^TM dual-therapy stent: What we plan to learn from REDUCE